drugset / Trial / NCT04821674
Study of DS-5670a (COVID-19 Vaccine) in Japanese Healthy Adults and Elderly Subjects
RandomizedParallel-groupTriple-blindPrevention
Summary
This study will assess the safety, tolerability and immunogenicity of DS-5670a (COVID-19 Vaccine) and determine the recommended dose in Japanese healthy adults and elderly participants.
Timeline
- Start
- 2021-03-15
- Primary completion
- 2021-08-13
- Completion
- 2022-07-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DS-5670a | Vaccine | 10 ug | Intramuscular |
| Subject | DS-5670a | Vaccine | 30 ug | Intramuscular |
| Subject | DS-5670a | Vaccine | 60 ug | Intramuscular |
| Subject | DS-5670a | Vaccine | 100 ug | Intramuscular |